Depressive symptoms predict increased incidence of neuropsychiatric side effects in patients treated with efavirenz.
Boly
Larry
L
Cafaro
Virginia
V
Dyner
Toby
T
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D003863:Depression / Q000150:complications*; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D010078:Oxazines / Q000009:adverse effects*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz